Type 2 diabetes treatment approved for children and adolescents
18 June 2019 | By Victoria Rees (European Pharmaceutical Review)
The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.
List view / Grid view
Clinical Trials
More countries added to the EU-US mutual recognition agreement
13 June 2019 | By European Pharmaceutical Review
Luxembourg and the Netherlands have been included in the mutual recognition agreement between the EU and the FDA in the US.
Amyloidosis treatment discontinued from clinical trials
10 June 2019 | By European Pharmaceutical Review
A treatment for amyloidosis has been pulled from clinical trials after failing to reach endpoints.
Influenza A vaccine enters Phase IIb trial
5 June 2019 | By Victoria Rees (European Pharmaceutical Review)
Novel influenza A vaccine has been administered to first patients in Phase IIb trial.
NICE recommends Prevymis on the NHS after re-evaluation
4 June 2019 | By European Pharmaceutical Review
The National Institute for Health and Care Excellence is recommending MSD’s Prevymis (letermovir) within the NHS.
WHO announces support for drug pricing transparency
31 May 2019 | By European Pharmaceutical Review
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.
First PI3K inhibitor for breast cancer approved by FDA
29 May 2019 | By European Pharmaceutical Review
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.
Mirikizimab moved to Phase III after positive trial findings
23 May 2019 | By Victoria Rees (European Pharmaceutical Review)
Eli Lilly presents new data for their mirikizimab treatment for Crohn’s disease.
Study shows that clinical research in England is ‘thriving’
20 May 2019 | By European Pharmaceutical Review
Research shows that the NHS continues to provide the optimum environment for the life sciences industry to deliver research.
Once-per-month HIV drugs could soon be available
16 May 2019 | By European Pharmaceutical Review
According to a recent article, drug companies are developing longer-acting, injectable HIV treatments.
Clinical trial tests injectable vs oral HIV medications
10 May 2019 | By European Pharmaceutical Review
A new clinical trial will determine if monthly injections of anti-viral drugs are more effective at suppressing the HIV virus than daily pills.
New drug for Huntington lowers levels of disease-causing protein
9 May 2019 | By European Pharmaceutical Review
A new drug for Huntington disease is found to be safe and lowers levels of the abnormal protein that causes the debilitating disease in patients.
FDA approves novel treatments for heart disease
8 May 2019 | By European Pharmaceutical Review
The US Food and Drug Administration (FDA) has approved new treatments for heart disease caused by ATTR-CM in adults.
New digital filter aims to improve chemical measurements
8 May 2019 | By European Pharmaceutical Review
A filter has been designed to create more exact measurements early in the drug development stage and help move a drug to clinical trials faster.
Novel colorectal cancer vaccine shows positive phase I results
2 May 2019 | By European Pharmaceutical Review
A new vaccine for colorectal cancer has proven to be safe in a small sample of human subjects, opening the way for the next phase of testing.
Follow: